Blood pressure screening also increased from 30% to 34% (of the undiagnosed population) between 2013 and 2014. In contrast, adequate control of cholesterol levels was achieved in only around 45% people with dyslipidaemia. The evaluation considered reasons for falling short of the 55% target, including poor adherence to clinical guidelines or deficient information systems.